Practical and general synthesis of 5′-adenylated RNA (5′-AppRNA)

Research output: Contribution to journalArticle

Abstract

A simple strategy is reported for 5′-adenylation of nearly any RNA sequence of indefinite length. The 5′-adenylated product (5′-AppRNA) is an activated RNA that is structurally similar to 5′-triphosphorylated RNA, which is usually prepared by in vitro transcription using T7 RNA polymerase. In the new 5′-adenylation strategy, the RNA substrate is first 5′-monophosphorylated either by T4 polynucleotide kinase, by in vitro transcription in the presence of excess GMP, or by appropriate derivatization during solid-phase synthesis. The RNA is then 5′-adenylated using ATP and T4 RNA ligase, in an interrupted version of the natural adenylation-ligation mechanism by which T4 RNA ligase joins two RNA substrates. Here, the final ligation step of the mechanism is inhibited with complementary DNA blocking oligonucleotide(s) that permit adenylation to occur with good yield. The 5′-AppRNA products of this approach should be valuable as activated RNAs for in vitro selection experiments as an alternative to 5′-triphosphorylated RNAs, among other likely applications. The 5′-terminal nucleotide of an RNA substrate to be adenylated using the new method is not restricted to guanosine, in contrast to 5′ -triphosphorylated RNA prepared by in vitro transcription. Therefore, using the new approach, essentially any RNA obtained from solid-phase synthesis or other means can be activated by 5′-adenylation in a practical manner.

Original languageEnglish (US)
Pages (from-to)731-746
Number of pages16
JournalRNA
Volume10
Issue number4
DOIs
StatePublished - Apr 1 2004

Fingerprint

RNA
Solid-Phase Synthesis Techniques
Ligation
RNA Ligase (ATP)
Polynucleotide 5'-Hydroxyl-Kinase
Guanosine
Ligases
Oligonucleotides
Nucleotides
Complementary DNA
In Vitro Techniques

Keywords

  • Adenylation
  • Blocking oligo
  • RNA ligation
  • T4 RNA ligase
  • Triphosphate

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology

Cite this

Practical and general synthesis of 5′-adenylated RNA (5′-AppRNA). / Silverman, Scott K.

In: RNA, Vol. 10, No. 4, 01.04.2004, p. 731-746.

Research output: Contribution to journalArticle

@article{f3f7112fad70464aa025b420b0337251,
title = "Practical and general synthesis of 5′-adenylated RNA (5′-AppRNA)",
abstract = "A simple strategy is reported for 5′-adenylation of nearly any RNA sequence of indefinite length. The 5′-adenylated product (5′-AppRNA) is an activated RNA that is structurally similar to 5′-triphosphorylated RNA, which is usually prepared by in vitro transcription using T7 RNA polymerase. In the new 5′-adenylation strategy, the RNA substrate is first 5′-monophosphorylated either by T4 polynucleotide kinase, by in vitro transcription in the presence of excess GMP, or by appropriate derivatization during solid-phase synthesis. The RNA is then 5′-adenylated using ATP and T4 RNA ligase, in an interrupted version of the natural adenylation-ligation mechanism by which T4 RNA ligase joins two RNA substrates. Here, the final ligation step of the mechanism is inhibited with complementary DNA blocking oligonucleotide(s) that permit adenylation to occur with good yield. The 5′-AppRNA products of this approach should be valuable as activated RNAs for in vitro selection experiments as an alternative to 5′-triphosphorylated RNAs, among other likely applications. The 5′-terminal nucleotide of an RNA substrate to be adenylated using the new method is not restricted to guanosine, in contrast to 5′ -triphosphorylated RNA prepared by in vitro transcription. Therefore, using the new approach, essentially any RNA obtained from solid-phase synthesis or other means can be activated by 5′-adenylation in a practical manner.",
keywords = "Adenylation, Blocking oligo, RNA ligation, T4 RNA ligase, Triphosphate",
author = "Silverman, {Scott K}",
year = "2004",
month = "4",
day = "1",
doi = "10.1261/rna.5247704",
language = "English (US)",
volume = "10",
pages = "731--746",
journal = "RNA",
issn = "1355-8382",
publisher = "Cold Spring Harbor Laboratory Press",
number = "4",

}

TY - JOUR

T1 - Practical and general synthesis of 5′-adenylated RNA (5′-AppRNA)

AU - Silverman, Scott K

PY - 2004/4/1

Y1 - 2004/4/1

N2 - A simple strategy is reported for 5′-adenylation of nearly any RNA sequence of indefinite length. The 5′-adenylated product (5′-AppRNA) is an activated RNA that is structurally similar to 5′-triphosphorylated RNA, which is usually prepared by in vitro transcription using T7 RNA polymerase. In the new 5′-adenylation strategy, the RNA substrate is first 5′-monophosphorylated either by T4 polynucleotide kinase, by in vitro transcription in the presence of excess GMP, or by appropriate derivatization during solid-phase synthesis. The RNA is then 5′-adenylated using ATP and T4 RNA ligase, in an interrupted version of the natural adenylation-ligation mechanism by which T4 RNA ligase joins two RNA substrates. Here, the final ligation step of the mechanism is inhibited with complementary DNA blocking oligonucleotide(s) that permit adenylation to occur with good yield. The 5′-AppRNA products of this approach should be valuable as activated RNAs for in vitro selection experiments as an alternative to 5′-triphosphorylated RNAs, among other likely applications. The 5′-terminal nucleotide of an RNA substrate to be adenylated using the new method is not restricted to guanosine, in contrast to 5′ -triphosphorylated RNA prepared by in vitro transcription. Therefore, using the new approach, essentially any RNA obtained from solid-phase synthesis or other means can be activated by 5′-adenylation in a practical manner.

AB - A simple strategy is reported for 5′-adenylation of nearly any RNA sequence of indefinite length. The 5′-adenylated product (5′-AppRNA) is an activated RNA that is structurally similar to 5′-triphosphorylated RNA, which is usually prepared by in vitro transcription using T7 RNA polymerase. In the new 5′-adenylation strategy, the RNA substrate is first 5′-monophosphorylated either by T4 polynucleotide kinase, by in vitro transcription in the presence of excess GMP, or by appropriate derivatization during solid-phase synthesis. The RNA is then 5′-adenylated using ATP and T4 RNA ligase, in an interrupted version of the natural adenylation-ligation mechanism by which T4 RNA ligase joins two RNA substrates. Here, the final ligation step of the mechanism is inhibited with complementary DNA blocking oligonucleotide(s) that permit adenylation to occur with good yield. The 5′-AppRNA products of this approach should be valuable as activated RNAs for in vitro selection experiments as an alternative to 5′-triphosphorylated RNAs, among other likely applications. The 5′-terminal nucleotide of an RNA substrate to be adenylated using the new method is not restricted to guanosine, in contrast to 5′ -triphosphorylated RNA prepared by in vitro transcription. Therefore, using the new approach, essentially any RNA obtained from solid-phase synthesis or other means can be activated by 5′-adenylation in a practical manner.

KW - Adenylation

KW - Blocking oligo

KW - RNA ligation

KW - T4 RNA ligase

KW - Triphosphate

UR - http://www.scopus.com/inward/record.url?scp=1642569624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642569624&partnerID=8YFLogxK

U2 - 10.1261/rna.5247704

DO - 10.1261/rna.5247704

M3 - Article

C2 - 15037782

AN - SCOPUS:1642569624

VL - 10

SP - 731

EP - 746

JO - RNA

JF - RNA

SN - 1355-8382

IS - 4

ER -